Combinatorially selected guanosine-quartet structureis a potent inhibitor of human immunodeficiency virus envelope-mediated cellfusion.

Jacqueline R. Wyatt, Timothy A. Vickers, Joseph L. Roberson, Robert W. Buckheit, Thomas Klimkait, Elizabeth L. DeBaets, Peter W. Davis, Bernard Rayner, J.‐L. IMBACH, David J. Ecker

Proceedings of the National Academy of Sciences · 1994 · 300 citations · 33 references

DOIFull text

Open access

Concepts

Abstract

The phosphorothioate oligonucleotide T2G4T2 was identified as an inhibitor of HIV infection in vitro by combinatorial screening of a library of phosphorothioate oligonucleotides that contained all possible octanucleotide sequences. The oligonucleotide forms a parallel-stranded tetrameric guanosine-quartet structure. Tetramer formation and the phosphorothioate backbone are essential for antiviral activity. The tetramer binds to the human immunodeficiency virus envelope protein gp120 at the V3 loop and inhibits both cell-to-cell and virus-to-cell infection.

References

33